This application includes a Sequence Listing in electronic format as a txt file entitled “EKUT-01-0103USWO_2017-05-01_U3077WOUS_US15523637_SEQLIST_ST25,” which was created on May 1, 2017 and which has a size of 7,230 bytes. The contents of txt file “EKUT-01-0103USWO_2017-05-01_U3077WOUS_US15523637_SEQLIST_ST25” are incorporated by reference herein.
The present invention relates to plants having increased resistance to plant pathogens as well as the method for producing increased pathogen resistance in plants by influencing the intracellular concentration of inositol pyrophosphates, in particular of InsP8.
Plants are constantly exposed to plant pathogens. In particular, herbivorous insects and their larvae, as well as fungi and fungi-like pathogens (e.g. oomycetes). Conservative estimates propose that the agronomic damage caused by Botrytis species alone is estimated to be around 1 Billion/year1. The resulting damages are caused not only by immediate harvest loss, but also by the loss of quality of products (for example by enrichment of mycotoxins).
A conventional method for fighting off insects and fungal pathogens is the use of chemical plant protection products. However, these measures often result in a loss of a part of the yields. The use of chemical plant protection products in crops can have a negative impact on people and the environment. Furthermore, these measures are very cost- and labor-intensive. Moreover, the pathogens to be combated with chemical plant protection products frequently develop adaptation mechanisms so that such measures often do not achieve the desired protective effect.
An alternative to the use of chemical agents is the use of insect and fungus resistant varieties. A breeding of new varieties using conventional plant breeding is very tedious and difficult because of the complexity of plant genomes; conventional plant cultivation usually uses spontaneous or induced mutations, the manifestations of which are not influenced by external factors (eg. cold-shocks or radioactive irradiation).
An alternative to conventional breeding is the production of genetically modified plants. Genes with desired properties are specifically introduced into the genome of the plants. Currently, in particular herbicide- and insect-resistant plants are marketed as genetically modified plants. The goal of the new generation of varieties is the increase in yield under adverse conditions, such as dry stress or insect infestation.
Mostly genetically modified maize and cotton plants with insect resistance are currently being cultivated. In most cases this property is derived from the Bt toxin, which is encoded by a gene introduced into the plants. The gene originates from the soil bacterium Bacillus thuringiensis, which naturally produces this active ingredient. One of the problems of this strategy is, however, that the first resistances have already developed in plant pathogens.
Furthermore, many scientific papers have shown that the Bt maize harms butterflies and endangers numerous other non-target organisms. Bt toxins are only slowly degraded, accumulate in the soil and are passed on in the food chain. Similar to the use of Bt toxins in biologic plant protection, as well as the control of mosquitoes, the cultivation of Bt maize therefore entails a wide range of risks to biodiversity.
The object of the present invention is, therefore, to provide plants with elevated resistance to plant pathogens, as well as processes for the preparation thereof, which do not harbor the disadvantages of the long-term toxicity of active substances known from the prior art, for example, by accumulation in the soil. Moreover, by providing such plants, and methods respectively, the spectrum of possible measures against pathogens shall be expanded and thereby the probability of resistance development be minimized.
This object is achieved by providing plants in which the intracellular concentration of inositol pyrophosphates InsP7 and/or InsPe8 is increased in comparison to a wildtype plant.
In animal systems, inositol pyrophosphates have been described as important intracellular signaling molecules. In the present invention, it was shown for the first time that the proteins VIH2 and VIH1 inhibit the phosphorylation of inositol pyrophosphates InsP6 and InsP7, and that VIH2 in Arabidopsis seedlings is mainly responsible for the synthesis of the inositol pyrophosphate InsP8. The VIH2 transcript is primarily expressed in different vegetative tissues and induced by mechanical injury as well as by infestation by caterpillars, while the VIH1 transcript accumulates mainly in pollen.
In the present invention, it was shown that VIH2 (GenBank Accession: At3g0130) is involved in pathogen defense in plants (see examples).
The object of the present invention is achieved, in particular, by the provision of a plant with inducible or elevated expression of at least one protein which is involved in the synthesis of inositol pyrophosphates, in particular of InsP8.
One embodiment of the invention is a plant in which the expression and/or the activity of the protein VIH2 encoded by the nucleotide sequence 2 (GenBank Accession: At3g01310), or of a homologous protein which is capable of synthesizing inositol pyrophosphates, in particular InsP8, is inducible or is increased in the whole plant or in specific tissues in comparison with the wildtype plant.
In another embodiment of the invention, the plant is a plant in which the expression and/or the activity of the protein VIH1 encoded by the nucleotide sequence 1 (GenBank Accession: At5g 15070), or a homologous protein which is capable of synthesizing inositol pyrophosphates, in particular InsP8, is inducible or is increased in the whole plant or in specific tissues in comparison with the wildtype plant.
The nucleotide sequence 1 or the nucleotide sequence 2 can originate from one plant species, i.e. are expressed homologous, or are derived from another organism, i.e. are expressed heterologously. The heterologous expression can be of advantage, since post-transcriptional or post-translational regulatory mechanisms in the host organism (for example deactivation of the enzyme due to overproduction) can be circumvented frequently.
The inducibility of VIH2, VIH1 or its homologous proteins can be achieved by methods known to those skilled in the art. For example, the expression of corresponding nucleotide sequences can be achieved under the control of an inducible promoter in the target plant. Known inducible expression systems that have already been successfully used in Arabidopsis, tobacco, rice, or maize normally consist of two components: a (often chimeric) transcription factor that is constitutively or tissue-specific expressed and the actual promoter that controls the expression of the desired nucleotide sequence. This promoter can be activated by the chimeric transcription factor by an external stimulus. Known examples are ethanol-inducible (“AlcR/AlcA”-system), dexamethasone-inducible (GR-fusions, GVG- and pOp/LhGR-systems), β-estradiol-inducible (XVE/OlexA system) and heat shock-inducible expression systems.
For the induced expression, promoters naturally occurring in the target plant, which are, for example, induced by pathogens, could also be used. Known examples are, for example, promotors which regulate the expression of the transcripts of the JAZ (“jasmonate ZIM-domain”) proteins which are important in the jasmonate metabolism and occur in all higher plants.
The increased expression (over-expression) of VIH2, VIH1 or its homologous proteins can be achieved by methods known to those skilled in the art. Thus, the expression of corresponding nucleotide sequences can be carried out under the transcriptional control of a constitutive promoter, for example the cauliflower mosaic virus promoter CaMV 35S or an ubiquitin (UBQ) promoter. It is also possible to use tissue-specific promoters which are, for example, expressed only in the tissues potentially infected by pathogens, such as, leaf, fruit or seed specific promoters.
The invention also relates to a method for increasing plant resistance against plant pathogens, wherein the intracellular concentration of inositol pyrophosphates InsP7 and/or InsP8, is modulated or is increased in comparison with the wildtype plant.
The intracellular concentration of inositol pyrophosphates InsP7 and/or InsP8 can be achieved, in particular, by inducible or constitutive expression and/or activity of VIH2, VIH1 or their homologous proteins.
In an alternative embodiment, the intracellular concentration of inositol pyrophosphates InsP7 and/or InsP8, is increased by treating the plants with the substrate for InsP7 (the precursor of InsP8), with InsP8 and/or with InsP7 or InsP8 derivatives, for example in the form of spraying, sprinkling or the like. In this case, membrane permeable esters are of particular interest, for example, those that have been developed for the exogenous application of the messenger InsP3
The plant pathogens against which the plant according to the invention is resistant are, in particular, herbivore insects, for example larvae of agricultural relevant pests, such as the small cabbage white or the owlet moth, as well as pathogenic fungi, such as necrotrophic fungi, for example representatives of the genera Alternaria or Botrytis.
The advantage of the present invention in contrast to the methods known from the prior art, for example, the expression of the Bt toxin from the bacterium Bacillus thuringiensis in plants, is that in the plant according to the invention endogenous mechanisms can be advantageously utilized for increasing resistance to plant pathogens and environmental stress. Since this entails the use of original plant genes and not of foreign species genes and substances, it can be assumed that the acceptance of such plants in the public is better than it is the case with conventional genetically modified plants. Moreover, it is not expected that the agricultural use of plants according to the invention will have a serious impact on non-target organisms and on the environment, such as the use of conventional insecticides or the cultivation of Bt plants. It can also be assumed that the resistance formation of pests, as opposed to conventional methods for the production of resistant plants, occurs more slowly, since the whole plant defense machinery against pathogens is induced by inositol pyrophosphates and not just individual toxins.
Further advantages, features and possible applications of the invention are described in the following with reference to the below described exemplary embodiment referring to the figures.
The experiments were performed with isogenic lines of the same ecotype (Arabiopsis thaliana, Col-0), which are characterized by presence (Col-0) and absence (vih2-3 and vih2-4) of an intact VIH2 gene (and thus VIH2 protein), or by increased expression of the VIH2 kinase domain (CaMV 35S: VIH2). In the latter plants (CaMV 35S: VIH2), the kinase domain of the wild-type VIH2 gene was under the control of the strong viral CaMV 35S promoter. For this purpose, the VIH2 kinase sequence was amplified by an Arabidopsis cDNA and inserted into the vector pENTR™/D-TOPO® (Invitrogen Life Technologies). From there the VIH2 kinase domain sequence was transferred by Gateway® LR Clonase™ II (Invitrogen Life Technologies) into the binary plant transformation vector pGWB441 (Nakagawa et al., 2007, Biosci. Biotechnol. Biochem, 71, 2095-2100). The vector produced thereby “pGWB441-VIH2 KD” was used for the transformation of Arabidopsis plants. Several independent transformants were selected on kanamycin, no longer segregating CaMV 35S: VIH2 T3 plants were established and an increased InsP8 biosynthesis was confirmed in these plants.
The exemplary embodiments indicate that VIH2 loss of function mutants have reduced resistance to herbivorous insects and nectrotrophic fungi (
Number | Date | Country | Kind |
---|---|---|---|
10 2014 016 774.7 | Nov 2014 | DE | national |
This U.S. non-provisional patent application is a U.S. national stage application, which was filed on May 1, 2017 under 35 U.S.C. §371 and claims priority to PCT Patent Application No. PCT/DE2015/000534, which was filed on Nov. 5, 2015, and to German Patent Application No. DE 10 2014 016 774.7, which was filed on Nov. 12, 2014. The contents of PCT Patent Application No. PCT/DE2015/000534 and German Patent Application No. DE 10 2014 016 774.7 are incorporated herein by reference in their entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/DE2015/000534 | 11/5/2015 | WO | 00 |